Manifaxine
From Infogalactic: the planetary knowledge core
Jump to: navigation, search
Systematic (IUPAC) name | |
---|---|
(2S,3S,5R)-2-(3,5-difluorophenyl)-3,5-dimethylmorpholin-2-ol
|
|
Identifiers | |
CAS Number | 135306-39-7 Y |
ATC code | none |
PubChem | CID: 60829 |
ChemSpider | 54816 N |
UNII | J8IE53G2IV Y |
Chemical data | |
Formula | C12H15F2NO2 |
Molecular mass | 243.249 g/mol |
|
|
|
|
NY (what is this?) (verify) |
Manifaxine (GW-320,659) is a drug developed by GlaxoSmithKline through structural modification of radafaxine, one of the major active metabolites[citation needed] of bupropion. It acts as a norepinephrine-dopamine reuptake inhibitor (NDRI). It was researched for treatment of ADHD and obesity and was shown to be safe, reasonably effective and well tolerated for both applications,[1][2] but no results have been reported following these initial trials and its current status is unclear.
See also
References
- ↑ DeVeaugh-Geiss J, Conners CK, Sarkis EH, Winner PK, Ginsberg LD, Hemphill JM, Laurenza A, Barrows CE, Webster CJ, Stotka CJ, Asgharnejad M. GW320659 for the treatment of attention-deficit/hyperactivity disorder in children. Journal of the American Academy of Child and Adolescent Psychiatry. 2002 Aug;41(8):914-20. PMID 12162627
- ↑ Spraggs CF, Pillai SG, Dow D, Douglas C, McCarthy L, Manasco PK, Stubbins M, Roses AD. Pharmacogenetics and obesity: common gene variants influence weight loss response of the norepinephrine/dopamine transporter inhibitor GW320659 in obese subjects. Pharmacogenetics and Genomics. 2005 Dec;15(12):883-9. PMID 16272960
<templatestyles src="Asbox/styles.css"></templatestyles>
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
Categories:
- Chemical articles having calculated molecular weight overwritten
- Articles with changed InChI identifier
- Infobox drug articles without a structure image
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Articles with unsourced statements from March 2016
- Alcohols
- Stimulants
- GlaxoSmithKline
- Norepinephrine-dopamine reuptake inhibitors
- Morpholines
- Organofluorides
- Nervous system drug stubs